Insights and Stories of greg-roumeliotis

Sep. 14, 2016 at 10:28 am CDT

New York/Frankfurt | Reuters — German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of US$66 billion including debt, ending months of wrangling after increasing its bid for a third time. The $128 a share deal announced on Wednesday, up […]

By greg-roumeliotis, Ludwig Burger

Sep. 6, 2016 at 1:50 am CDT

Reuters — German pharmaceutical and crops manufacturer Bayer said on Monday that its negotiations with Monsanto had advanced, and that it was now willing to offer more than US$65 billion to acquire the world’s largest seeds company. Bayer’s announcement came as the gap in price expectations between the two companies […]

By greg-roumeliotis, Ludwig Burger

Jul. 19, 2016 at 2:54 pm CDT

(Reuters) — U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG, but said it was open to further talks with the German healthcare and chemicals group as well as other parties. The widely expected rejection puts pressure on Bayer to sweeten its offer […]

By greg-roumeliotis, Ludwig Burger

Jul. 14, 2016 at 12:40 pm CDT

Reuters — German drug and crop chemical group Bayer on Thursday announced details of a sweetened US$64 billion bid for Monsanto as it tries to put the U.S. seed company under pressure to engage further. The move shows the two companies have made little progress in their negotiations since Monsanto […]

By greg-roumeliotis

Jun. 10, 2016 at 6:48 pm CDT

Reuters — Monsanto, the world’s largest seed company, has still not opened its books more than two weeks after it rejected Bayer AG’s US$62 billion acquisition offer but left the door open to a possible deal, according to people familiar with the matter. The impasse shows that little progress in […]

By greg-roumeliotis